Jetté Nathalie, Amoozegar Farnaz, Patten Scott B
Department of Clinical Neurosciences (NJ, FA), Hotchkiss Brain Institute (NJ, FA, SBP), Department of Psychiatry (SBP), Mathison Health Centre (SBP), Department of Community Health Sciences (NJ, FA, SBP), and O'Brien Institute for Public Health (NJ, FA, SBP), Cumming School of Medicine, University of Calgary, Canada.
Neurol Clin Pract. 2017 Apr;7(2):118-127. doi: 10.1212/CPJ.0000000000000349.
To provide an overview of the epidemiology of depression in chronic neurologic conditions that can affect individuals throughout the lifespan (epilepsy, migraine, multiple sclerosis [MS]) and examine depression screening tools for adults with these conditions.
Depression is common in neurologic conditions and can be associated with lower quality of life, higher health resource utilization, and poor adherence to treatment. It affects around 20%-30% of those with epilepsy, migraine, and MS, and evidence for a bidirectional association exists for each of these conditions. Depression screening tools generally perform well in neurologic conditions, but are not without limitations.
Depression is a major contributor to poor outcomes in epilepsy, migraine, and MS. Although psychiatric resources are scarce globally, this is no reason to ignore depression in neurologic conditions. Depression screening tools are available in neurology and should be considered in clinical practice.
概述慢性神经系统疾病中抑郁症的流行病学情况，这些疾病可影响个体一生（癫痫、偏头痛、多发性硬化症[MS]），并研究针对患有这些疾病的成年人的抑郁症筛查工具。
抑郁症在神经系统疾病中很常见，可能与生活质量降低、更高的医疗资源利用率以及治疗依从性差有关。它影响约20%-30%的癫痫、偏头痛和MS患者，并且每种疾病都存在双向关联的证据。抑郁症筛查工具在神经系统疾病中通常表现良好，但并非没有局限性。
抑郁症是导致癫痫、偏头痛和MS不良结局的主要因素。尽管全球精神科资源稀缺，但这绝不是忽视神经系统疾病中抑郁症的理由。神经科有抑郁症筛查工具，临床实践中应予以考虑。
